InvestorsHub Logo
icon url

Scott999

10/24/18 2:58 PM

#17326 RE: Auto1 #17323

This is the one company that could leap frog right over us in a heartbeat. Their diabetic foot trial has most if not all outcome measures we do, and are expecting phase 2 results in November. Then who knows what the FDA could grant them. It is, a serious disease after all, that meets an unmet need.

Would sure make the two year delay by Zami to build out manufacturing, a momentous gaff on his part. Time will tell.

https://clinicaltrials.gov/ct2/show/NCT02264288?term=Celularity&rank=5